1. Home
  2. BEATW vs NYMTM Comparison

BEATW vs NYMTM Comparison

Compare BEATW & NYMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEATW
  • NYMTM
  • Stock Information
  • Founded
  • BEATW 2015
  • NYMTM N/A
  • Country
  • BEATW United States
  • NYMTM United States
  • Employees
  • BEATW 21
  • NYMTM 70
  • Industry
  • BEATW Retail: Computer Software & Peripheral Equipment
  • NYMTM Real Estate Investment Trusts
  • Sector
  • BEATW Technology
  • NYMTM Real Estate
  • Exchange
  • BEATW Nasdaq
  • NYMTM Nasdaq
  • Market Cap
  • BEATW N/A
  • NYMTM N/A
  • IPO Year
  • BEATW N/A
  • NYMTM N/A
  • Fundamental
  • Price
  • BEATW $0.60
  • NYMTM $24.01
  • Analyst Decision
  • BEATW
  • NYMTM
  • Analyst Count
  • BEATW 0
  • NYMTM 0
  • Target Price
  • BEATW N/A
  • NYMTM N/A
  • AVG Volume (30 Days)
  • BEATW 4.7K
  • NYMTM N/A
  • Earning Date
  • BEATW 03-14-2025
  • NYMTM N/A
  • Dividend Yield
  • BEATW N/A
  • NYMTM N/A
  • EPS Growth
  • BEATW N/A
  • NYMTM N/A
  • EPS
  • BEATW N/A
  • NYMTM N/A
  • Revenue
  • BEATW N/A
  • NYMTM N/A
  • Revenue This Year
  • BEATW N/A
  • NYMTM N/A
  • Revenue Next Year
  • BEATW N/A
  • NYMTM N/A
  • P/E Ratio
  • BEATW N/A
  • NYMTM N/A
  • Revenue Growth
  • BEATW N/A
  • NYMTM N/A
  • 52 Week Low
  • BEATW $0.50
  • NYMTM N/A
  • 52 Week High
  • BEATW $0.62
  • NYMTM N/A
  • Technical
  • Relative Strength Index (RSI)
  • BEATW N/A
  • NYMTM 52.94
  • Support Level
  • BEATW N/A
  • NYMTM $22.83
  • Resistance Level
  • BEATW N/A
  • NYMTM $23.78
  • Average True Range (ATR)
  • BEATW 0.00
  • NYMTM 0.41
  • MACD
  • BEATW 0.00
  • NYMTM 0.12
  • Stochastic Oscillator
  • BEATW 0.00
  • NYMTM 88.82

About BEATW Heartbeam Inc.

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About NYMTM New York Mortgage Trust Inc.

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.

Share on Social Networks: